CoreCap Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
CoreCap Advisors's HALO Position: Q3 2026 in Review
CoreCap Advisors increased its Halozyme (HALO) stake by 98% in Q3 2026, buying an estimated $14.5K and bringing the position to 303 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.
CoreCap Advisors first reported a position in HALO in Q3 2024 and has held it in 7 quarters since. The position peaked at $757K in Q4 2024. 161 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- CoreCap Advisors held 303 shares of Halozyme worth $33.5K as of Q3 2026.
- CoreCap Advisors bought 150 Halozyme shares in Q3 2026, an estimated $14.5K.
- Halozyme made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1584 holding.
- CoreCap Advisors first reported a position in Halozyme in Q3 2024 and has held it in 7 quarters since.
- CoreCap Advisors's Halozyme position peaked at $757K in Q4 2024.
- 161 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.